Prostate cancer prognostic marker

Fixemer, T., Wissenbach, U., Flockerzi, V. and Bonkhoff, H., 2003, Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer a novel prognostic marker for tumor progression. Oncogene 22, 7858-61. 

Bettencourt MC, Bauer JJ, Sesterhenn lA, et al. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy. J Urol. 1996 156 1064. 

Bauer JJ, Sesterhenn lA, Mostofi KF, et al. p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy. Clin Cancer Res. 1995 1 1295. 

Schmitz M, Grignard G, Margue C, et al. Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis. Int J Cancer. 2006. 

Honn KV, Aref A, Chen YQ, Cher ML, Crissman JD, Forman JD, Gao X, Grignon D, Hussain M, Porter AT, Pontes EJ, Powell II, Redman B, Sakr W, Severson R, Tang DG, Wood DP, Jr. Prostate Cancer -Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects). Pathol Oncol Res. 2 (1996) 191-211. 

Fu, Z., Kitagawa, Y, Shen, R., Shah, R., Mehra, R., Rhodes, D., Keller, P.J., Mizokami, A., Dunn, R., Chinnaiyan, A.M., et al. (2006). Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate. 66, 248-256. 

---